Target Price | $57.35 |
Price | $47.94 |
Potential |
19.63%
register free of charge
|
Number of Estimates | 20 |
20 Analysts have issued a price target US Bancorp 2026 .
The average US Bancorp target price is $57.35.
This is
19.63%
register free of charge
$65.00
35.59%
register free of charge
$51.00
6.38%
register free of charge
|
|
A rating was issued by 25 analysts: 13 Analysts recommend US Bancorp to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the US Bancorp stock has an average upside potential 2026 of
19.63%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 42.71 | 28.65 |
6.70% | 32.93% | |
Net Margin | 13.84% | 23.74% |
8.62% | 71.50% |
18 Analysts have issued a sales forecast US Bancorp 2025 . The average US Bancorp sales estimate is
This results in the following potential growth metrics:
21 US Bancorp Analysts have issued a net profit forecast 2025. The average US Bancorp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.79 | 4.36 |
15.90% | 15.04% | |
P/E | 11.00 | |
EV/Sales | 3.46 |
21 Analysts have issued a US Bancorp forecast for earnings per share. The average US Bancorp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the US Bancorp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley | Overweight ➜ Overweight | Unchanged | Jan 17 2025 |
Oppenheimer | Outperform ➜ Outperform | Unchanged | Jan 17 2025 |
Truist Securities | ➜ Hold | Initiated | Jan 07 2025 |
Barclays | Overweight ➜ Overweight | Unchanged | Jan 06 2025 |
Oppenheimer | Outperform ➜ Outperform | Unchanged | Jan 03 2025 |
DA Davidson | Neutral ➜ Buy | Upgrade | Jan 02 2025 |
Raymond James | Market Perform ➜ Outperform | Upgrade | Dec 19 2024 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley: Overweight ➜ Overweight
|
Jan 17 2025 |
Unchanged
Oppenheimer: Outperform ➜ Outperform
|
Jan 17 2025 |
Initiated
Truist Securities: ➜ Hold
|
Jan 07 2025 |
Unchanged
Barclays: Overweight ➜ Overweight
|
Jan 06 2025 |
Unchanged
Oppenheimer: Outperform ➜ Outperform
|
Jan 03 2025 |
Upgrade
DA Davidson: Neutral ➜ Buy
|
Jan 02 2025 |
Upgrade
Raymond James: Market Perform ➜ Outperform
|
Dec 19 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.